Dementia is one of many disorders with gender differences (Mazure and Swendsen, Reference Mazure and Swendsen2016) and women show a greater prevalence of dementia than men (Winblad et al., Reference Winblad, Amouyel, Andrieu, Ballard, Brayne, Brodaty, Cedazo-Minguez, Dubois, Edvardsson and Feldman2016). However, longitudinal cohort studies investigating whether the incidence of dementia differs by gender have shown conflicting results. Prospective cohort studies in high-income countries (HIC) such as the USA, the Netherlands and the UK reported no gender differences in the incidence of dementia (Bachman et al., Reference Bachman, Wolf, Linn, Knoefel, Cobb, Belanger, White and D'agostino1993; Paykel et al., Reference Paykel, Brayne, Huppert, Gill, Barkley, Gehlhaar, Beardsall, Girling, Pollitt and O'connor1994; Ruitenberg et al., Reference Ruitenberg, Ott, Van Swieten, Hofman and Breteler2001). On contrary, the 10/66 Dementia Research Group used longitudinal data from six middle-income countries (MIC), including Cuba, the Dominican Republic, Venezuela, Peru, Mexico and China and found that women showed a higher risk of incident dementia than men even after controlling for age, education and occupational attainment (Prince et al., Reference Prince, Acosta, Ferri, Guerra, Huang, Rodriguez, Salas, Sosa, Williams, Dewey, Acosta, Jotheeswaran and Liu2012). Higher rates of incident dementia for women in MIC but not HIC may be attributable to the greater gender differences in education, socialeconomic status, lifestyle and health conditions of MIC compared to those of HIC (Medel-Anonuevo, Reference Medel-Anonuevo1995). Pregnancy and childbirth are the most distinctive experiences of women that may change hormone levels, health conditions and lifestyles, and women in MIC have more childbirths on average than women in HIC (United Nations, 2019).
Several studies have shown parity to be associated with the risks for cognitive impairment and dementia. In a case-control study from Germany, the chances of having at least one child and the number of children were both greater among 106 women with Alzheimer's disease (AD) than among 189 women without dementia (Ptok et al., Reference Ptok, Barkow and Heun2002). In a cross-sectional study from China on 4796 postmenopausal women, grand multiparous women (five or more childbirths) showed about 1.3-fold higher risk of cognitive impairment than women with 1–4 parities (Li et al., Reference Li, He, Chen, Xiao, Lin, Shen, Wang, Zhai, Shang and Lin2016). In a retrospective analysis on the pooled data of 3549 women from two population-based cohort studies in Korea and Greece, we found that grand multiparous women showed about 1.7-fold higher risk of AD than women with one–four parities (Jang et al., Reference Jang, Bae, Dardiotis, Scarmeas, Sachdev, Lipnicki, Han, Kim, Kwak and Kim2018). However, the risk of dementia associated with parity reported from these previous studies employing case-control or cross-sectional designs is subject to various biases; a selection bias (Tripepi et al., Reference Tripepi, Jager, Dekker and Zoccali2010) due to the shorter life expectancy of grand multiparous women than women with four parities or less (Hinkula et al., Reference Hinkula, Kauppila, Nayha and Pukkala2006), a prevalence-incidence bias (Hill, Reference Hill2003) due to the lower mortality from dementia in grand multiparous women than women with four parities or less (Hinkula et al., Reference Hinkula, Kauppila, Nayha and Pukkala2006) and information bias (Tripepi et al., Reference Tripepi, Jager, Dekker and Zoccali2010) due to the greater risk of inaccurate information on parity from dementia patients than from cognitively normal elderly individuals.
In this study, we conducted a pooled analysis on the longitudinal data from six population-based prospective cohort studies (four European and two Asian cohorts) to more accurately determine the effect of parity on the risk of incident dementia in older women.
We pooled baseline and follow-up data for community-dwelling women aged 60 or older from six members of the Cohort Studies of Memory in an International Consortium (COSMIC) collaboration (Table 1) (Riedel-Heller et al., Reference Riedel-Heller, Busse, Aurich, Matschinger and Angermeyer2001; Lobo et al., Reference Lobo, Lopez-Anton, Santabarbara, De-La-Cámara, Ventura, Quintanilla, Roy, Campayo, Lobo and Palomo2011; Sachdev et al., Reference Sachdev, Lipnicki, Kochan, Crawford, Rockwood, Xiao, Li, Li, Brayne and Matthews2013; Dardiotis et al., Reference Dardiotis, Kosmidis, Yannakoulia, Hadjigeorgiou and Scarmeas2014; Ding et al., Reference Ding, Zhao, Guo, Meng, Wang, Yu, Luo, Zhou, Yu, Zheng, Chu, Mortimer, Borenstein and Hong2014; Thorvaldsson et al., Reference Thorvaldsson, Karlsson, Skoog, Skoog and Johansson2017; Han et al., Reference Han, Kim, Kwak, Kim, Kim, Kim, Kim, Kim, Moon, Park, Park, Byun, Suh, Seo, So, Ryu, Youn, Lee, Lee, Lee, Lee, Lee, Lee, Jeong, Jeong, Jhoo, Han, Hong and Kim2018). The included cohorts varied in size from 1016 to 6818 participants. From an initial sample of 11 300 women, we excluded 1010 who did not have data on educational level, hypertension, diabetes mellitus (DM) or parity and 534 diagnosed as having dementia at baseline, giving a final sample of 9756 women.
H70, Gothenburg H70 Birth Cohort Studies; HELIAD, Hellenic Longitudinal Investigation of Aging and Diet; KLOSCAD, Korean Longitudinal Study on Cognitive Aging and Dementia; LEILA75+, Leipzig Longitudinal Study of the Aged; SAS, Shanghai Aging Study; ZARADEMP, Zaragoza Dementia Depression Project.
The participants of all studies were randomly sampled.
a Numbers at the baseline assessment.
b Mean ± standard deviation (range).
c Mean ± standard deviation (range), numbers of children in the H70 and LEILA 75+ and numbers of childbirths in other studies.
This study was approved by the University of New South Wales Human Research Ethics Committee (Ref: # HC12446). Each of the six contributing studies had previously obtained ethics approval from their respective institutional review boards and all participants provided informed consent.
The main outcomes of the present analysis were incident all-cause dementia, AD and non-Alzheimer dementia (NAD). All studies provided data on dementia diagnosis, based on DSM-IV criteria (American Psychiatric Association, 1994) in five studies (Riedel-Heller et al., Reference Riedel-Heller, Busse, Aurich, Matschinger and Angermeyer2001; Lobo et al., Reference Lobo, Lopez-Anton, Santabarbara, De-La-Cámara, Ventura, Quintanilla, Roy, Campayo, Lobo and Palomo2011; Dardiotis et al., Reference Dardiotis, Kosmidis, Yannakoulia, Hadjigeorgiou and Scarmeas2014; Ding et al., Reference Ding, Zhao, Guo, Meng, Wang, Yu, Luo, Zhou, Yu, Zheng, Chu, Mortimer, Borenstein and Hong2014; Han et al., Reference Han, Kim, Kwak, Kim, Kim, Kim, Kim, Kim, Moon, Park, Park, Byun, Suh, Seo, So, Ryu, Youn, Lee, Lee, Lee, Lee, Lee, Lee, Jeong, Jeong, Jhoo, Han, Hong and Kim2018) and DSM-III-R criteria (American Psychiatric Association, 1987) in one (Thorvaldsson et al., Reference Thorvaldsson, Karlsson, Skoog, Skoog and Johansson2017). Four studies (Dardiotis et al., Reference Dardiotis, Kosmidis, Yannakoulia, Hadjigeorgiou and Scarmeas2014; Ding et al., Reference Ding, Zhao, Guo, Meng, Wang, Yu, Luo, Zhou, Yu, Zheng, Chu, Mortimer, Borenstein and Hong2014; Thorvaldsson et al., Reference Thorvaldsson, Karlsson, Skoog, Skoog and Johansson2017; Han et al., Reference Han, Kim, Kwak, Kim, Kim, Kim, Kim, Kim, Moon, Park, Park, Byun, Suh, Seo, So, Ryu, Youn, Lee, Lee, Lee, Lee, Lee, Lee, Jeong, Jeong, Jhoo, Han, Hong and Kim2018) diagnosed AD according to the NINCDS-ADRDA criteria (McKhann et al., Reference McKhann, Drachman, Folstein, Katzman, Price and Stadlan1984) and two studies (Riedel-Heller et al., Reference Riedel-Heller, Busse, Aurich, Matschinger and Angermeyer2001; Lobo et al., Reference Lobo, Lopez-Anton, Santabarbara, De-La-Cámara, Ventura, Quintanilla, Roy, Campayo, Lobo and Palomo2011) according to DSM-IV criteria (American Psychiatric Association, 1994). The main exposure was the number of parities. We assigned parity as the number of childbirths in four cohorts and as the number of children in two cohorts. Other data included age, sex, educational level and the presence of hypertension and DM, which were all harmonised when necessary. For the presence of hypertension and DM, we used all available information from a study relevant to diagnoses (medical history record, self-reported history, use of relevant medication and measured blood pressure or glucose level exceeding values indicated by international guidelines).
We compared the continuous variables between groups using one-way analysis of variance with Scheffé's post hoc analysis and categorical variables using chi-square tests.
We evaluated the relationship between parity and incident dementia using Cox proportional hazards regression models with time-dependent covariates. We used calendar time as the time axis. The primary outcome was incident dementia and the risk factor of primary interest was the number of parities. Participants who developed dementia during follow-up were censored at the midpoint between their last assessment date when without dementia and their first assessment date when diagnosed with dementia. Participants who remained dementia-free during the follow-up were censored at the most recent assessment date. We initially analysed the number of parities as a continuous variable and estimated hazard ratios (HRs) and 95% confidence intervals (CIs) with unadjusted and adjusted Cox proportional hazards regression models. The adjusted model included age, educational level, hypertension, DM and cohort as covariates. Next, we categorised parity into three strata – no parity (nulliparity), 1–4 parities and five or more parities (grand multiparity) (Babinszki et al., Reference Babinszki, Kerenyi, Torok, Grazi, Lapinski and Berkowitz1999) because both grand multiparity and nulliparity have been previously associated with the risk of AD (Ptok et al., Reference Ptok, Barkow and Heun2002; Jang et al., Reference Jang, Bae, Dardiotis, Scarmeas, Sachdev, Lipnicki, Han, Kim, Kwak and Kim2018), as well as the risks of medical diseases such as DM and coronary heart disease (Lawlor, Reference Lawlor2003; Nicholson et al., Reference Nicholson, Asao, Brancati, Coresh, Pankow and Powe2006). We investigated the association of parity with the risks of AD, and NAD separately. We also analysed the four cohort studies that provided the number of childbirths and the two cohort studies that provided the number of children separately.
The KLOSCAD team harmonised and pooled the dataset and performed the analyses using the Statistical Package for Social Sciences, v20 (SPSS Inc., Chicago, IL).
Availability of data and materials
The data that support the findings of this study are available from the corresponding author upon reasonable request
Of 9756 women dementia-free at baseline, 7010 completed one or more follow-up assessments. The mean follow-up duration was 5.4 ± 3.1 years (Table 2). During the follow-up period, dementia developed in 550 participants (AD in 380 and NAD in 170). Compared to participants who remained dementia-free during follow-up, those who did not complete a follow-up assessment were older and less educated and those who developed dementia were older, had more hypertension and DM and gave more childbirths (Table 3).
H70, Gothenburg H70 Birth Cohort Studies; HELIAD, Hellenic Longitudinal Investigation of Aging and Diet; KLOSCAD, Korean Longitudinal Study on Cognitive Aging and Dementia; LEILA75+, Leipzig Longitudinal Study of the Aged; SAS, Shanghai Aging Study; ZARADEMP, Zaragoza Dementia Depression Project; AD, Alzheimer dementia; NAD, non-Alzheimer's disease.
a Mean ± standard deviation.
b Numbers of dementia-free participants at baseline who completed one or more follow-up assessments.
a Analysis of variance with Scheffe's posthoc comparison for continuous variables and chi square tests for categorical variables. The level of significance was considered to be P < 0.05.
Parity as continuous
As shown in Table 4, the risk of dementia increased by 7% for every parity in the adjusted Cox hazard model (HR = 1.07, 95% CI = 1.02–1.13). The risk of NAD increased by 12% for every parity (HR = 1.12, 95% CI = 1.02–1.23), but the risk of AD was not significantly associated with the number of parities (HR = 1.05, 95% CI = 0.99–1.11).
AD, Alzheimer's disease; NAD, non-Alzheimer's disease.
Values represent hazard ratio with 95% confidence intervals in the parentheses.
a Cox proportional hazards model adjusting for age, educational level, hypertension, diabetes mellitus and cohort.
Parity as categorical
Compared to the one–four parities group, grand multiparity increased the risk of dementia by 30% (HR = 1.30, 95% CI = 1.02–1.67) but nulliparity did not (HR = 0.84, 95% CI = 0.63–1.12). Grand multiparity increased the risk of NAD by 60% (HR = 1.60, 95% CI = 1.00–2.55), but was not associated with the risk of AD. Nulliparity was not associated with the risk of either NAD or AD (Table 4).
When we analysed the four cohort studies that provided the number of childbirths and the two cohort studies that provided the number of children separately, the number of parities was associated with the risk of dementia in both groups, although the association was not statistically significant in the cohorts that provided the number of children (HR = 1.08, 95% CI = 1.02–1.14 for the cohorts providing the number of childbirths; HR = 1.02, 95% CI = 0.91–1.14 for the cohorts providing the number of children).
We analysed pooled data for 7010 women older women drawn from six population-based prospective cohort studies, four in Europe and two in Asia. Our results show the number of parities to be associated with the risk of incident dementia. Grand multiparity increased the risk of dementia by 30%, which is comparable to the relative risk of dementia due to some well-known risk factors (1.37 for current/ever smoking (Beydoun et al., Reference Beydoun, Beydoun, Gamaldo, Teel, Zonderman and Wang2014), 1.41 for low social participation (Kuiper et al., Reference Kuiper, Zuidersma, Oude Voshaar, Zuidema, Van Den Heuvel, Stolk and Smidt2015), 1.33 for midlife obesity (Albanese et al., Reference Albanese, Launer, Egger, Prince, Giannakopoulos, Wolters and Egan2017) and 1.21 for vitamin D deficiency (Shen and Ji, Reference Shen and Ji2015)). Although the association of parity and the risk of dementia in women has been reported by case-control and cross-sectional studies (Ptok et al., Reference Ptok, Barkow and Heun2002; Jang et al., Reference Jang, Bae, Dardiotis, Scarmeas, Sachdev, Lipnicki, Han, Kim, Kwak and Kim2018), this is the first prospective study to demonstrate an association between them.
Studies from HIC have reported a similar rate of incident dementia for men and women (Bachman et al., Reference Bachman, Wolf, Linn, Knoefel, Cobb, Belanger, White and D'agostino1993; Paykel et al., Reference Paykel, Brayne, Huppert, Gill, Barkley, Gehlhaar, Beardsall, Girling, Pollitt and O'connor1994; Ruitenberg et al., Reference Ruitenberg, Ott, Van Swieten, Hofman and Breteler2001), but those from MIC showed women to have about 40% higher rates on incident dementia than men, even after controlling for age, educational level and occupational attainment (Prince et al., Reference Prince, Acosta, Ferri, Guerra, Huang, Rodriguez, Salas, Sosa, Williams, Dewey, Acosta, Jotheeswaran and Liu2012). In the 1960s MIC had a fertility rate of nearly 6, almost twice that of HIC (United Nations, 2019). Given this, our results suggest that greater rates of incident dementia for women than for men in MIC could be at least partly attributable to high fertility rates and a prevalence of grand multiparity that is over 20% (Mueller et al., Reference Mueller, Mueller, Odegaard, Gross, Koh, Yuan and Pereira2013; Jang et al., Reference Jang, Bae, Dardiotis, Scarmeas, Sachdev, Lipnicki, Han, Kim, Kwak and Kim2018; Solanke, Reference Solanke2019). Grand multiparity is also likely to be a risk for dementia among women in low-income countries for which the mean fertility rate was 4.6 in 2017 and where grand multiparity is still common (United Nations, 2019).
The association between parity and the risk of incident dementia is potentially explained by a number of mechanisms. First, low high-density lipoprotein (HDL) levels have been associated with the development of dementia (Rasmussen et al., Reference Rasmussen, Tybjærg-Hansen, Nordestgaard and Frikke-Schmidt2015) and AD (Reitz et al., Reference Reitz, Tang, Schupf, Manly, Mayeux and Luchsinger2010), and parous women were reported to have lower HDL levels than nulliparous women for 3 years after childbirth (Lewis et al., Reference Lewis, Funkhouser, Raczynski, Sidney, Bild and Howard1996). This appears to be a persistent effect, as a significant trend toward lower HDL levels with increasing parity has been shown in old age (Humphries et al., Reference Humphries, Westendorp, Bots, Spinelli, Carere, Hofman and Witteman2001). Second, changes in glucose metabolism induced by parity might increase the risk of dementia. We controlled for DM, which is a known risk factor of dementia (Ott et al., Reference Ott, Stolk, Van Harskamp, Pols, Hofman and Breteler1999). However, higher than average glucose levels in elderly individuals without DM have also been associated with an increased risk of incident dementia (Crane et al., Reference Crane, Walker, Hubbard, Li, Nathan, Zheng, Haneuse, Craft, Montine and Kahn2013). Insulin sensitivity drops to 50% in the third trimester of pregnancy and grand multiparity is associated with an increased risk of subsequent clinical insulin resistance in premenopausal women (Abdelsalam and Elamin, Reference Abdelsalam and Elamin2017). It has also been reported that postmenopausal women with four or more children have higher insulin resistance than nulliparous and primiparous women (Humphries et al., Reference Humphries, Westendorp, Bots, Spinelli, Carere, Hofman and Witteman2001). Third, estrogen has a neuroprotective effect (Barha and Galea, Reference Barha and Galea2010; Inagaki et al., Reference Inagaki, Gautreaux and Luine2010) and low serum bioavailable estradiol has been associated with the risk of cognitive impairment (Yaffe et al., Reference Yaffe, Lui, Grady, Cauley, Kramer and Cummings2000). Since parous women were found to have lower levels of a urinary estradiol metabolite than nulliparous women (Munro et al., Reference Munro, Stabenfeldt, Cragun, Addiego, Overstreet and Lasley1991; Barrett et al., Reference Barrett, Parlett, Windham and Swan2014), and a lower free estradiol index reportedly related to the number of parities in postmenopausal women (Chavez-MacGregor et al., Reference Chavez-Macgregor, Van Gils, Van Der Schouw, Monninkhof, Van Noord and Peeters2008), parity might affect the risk of dementia by exposing women to reduced serum estrogen for much of their adult life. Although these influences of multiparity may increase the risks of both AD and NAD, our results suggest that they may more strongly affect the risk of NAD. Cerebrovascular diseases that are closely associated with lipid and glucose metabolisms are the most common cause of NAD (Rizzi et al., Reference Rizzi, Rosset and Roriz-Cruz2014) and vascular dementia was the most common type of incident NAD in the current study.
This study has several strengths compared to previous studies that were case-control or cross-sectional. First, our dataset consists of more than 7000 elderly women from six international population-based cohorts, which is much larger and more representative than the datasets in previous studies. Second, the probability of information bias was relatively low. In case-control and cross-sectional studies, dementia patients with severe cognitive impairment might recall their parity experience incorrectly and it might introduce information bias. However, the current study obtained information on parity when the participants were dementia-free. Lastly, any effect of mortality on the results was also likely to be smaller. Cross-sectional studies assess participants at a single time point and dementia patients with a longer survival rate are more likely to be included than those with a shorter survival rate. Because grand multiparous women show a decreased risk of mortality from dementia (Hinkula et al., Reference Hinkula, Kauppila, Nayha and Pukkala2006), a prevalence-incidence bias might affect the results of cross-sectional studies.
This study also has limitations. Changes in lifestyle and behaviours induced by parity and socialeconomic status which associated with the number of parities could be associated with the risk of incident dementia and have affected our results, and while we controlled for educational level, hypertension, DM and cohort, other confounders might have influenced our outcomes. Adoption or death of children might have distorted parity information because parity data were based on the number of children in two cohorts and the number of childbirths in four cohorts. In addition, the effect of parity on the risk of dementia could be over- or under-estimated because we excluded about one-tenth of participants whose information on educational level, hypertension, DM or parity were not available.
In conclusion, grand multiparity is a significant risk factor for dementia in women. This may have particularly important implications for women in low and middle-income countries where the fertility rate and prevalence of grand multiparity are high.
The Sydney COSMIC team comprises Perminder S. Sachdev (head of COSMIC, and joint study leader of the Sydney Memory and Ageing Study); Darren M. Lipnicki (COSMIC study co-ordinator), Steve R Makkar, John D Crawford, Anbupalam Thalamuthu, Nicole A. Kochan, Yvonne Leung, and Jessica W. Lo.
Affiliations of the authors with the contributing studies are as follows (*indicates study leader or joint study leader):
Gothenburg H70 Birth cohort Studies: Ingmar Skoog*, Jenna Najar, Therese Rydberg Sterner;
Hellenic Longitudinal Investigation of Aging and Diet: Nikolaos Scarmeas*, Mary Yannakoulia, Efthimios Dardiotis; Korean Longitudinal Study on Cognitive Aging and Dementia: Ki Woong Kim*, Ji Won Han, Jong Bin Bae; Leipzig Longitudinal Study of the Aged: Steffi G. Riedel-Heller*, Susanne Roehr, Alexander Pabst;
Shanghai Aging Study: Ding Ding*. Qianhua Zhao, Xiaoniu Liang; Zaragoza Dementia Depression Project: Antonio Lobo*, Concepción De-la-Cámara, Elena Lobo.
Further COSMIC study leaders: Yuda Turana (Atma Jaya Cognitive & Aging Research), Erico Castro-Costa (Bambui Cohort Study of Aging), Bagher Larijani and Iraj Nabipour (Bushehr Elderly Health Program), Kenneth Rockwood (Canadian Study of Health & Aging), Xiao Shifu (Chinese Longitudinal Aging Study), Richard B. Lipton and Mindy J. Katz (Einstein Aging Study), Pierre-Marie Preux and Maëlenn Guerchet (Epidemiology of Dementia in Central Africa), Linda Lam (Hong Kong Memory and Ageing Prospective Study), Ingmar Skoog (Gothenburg H70 Birth Cohort Studies), Toshiharu Ninimiya (Hisayama Study), Richard Walker (Identification and Intervention for Dementia in Elderly Africans study), Hugh Hendrie (Indianapolis Ibadan Dementia Project), Juan J. Llibre-Rodriguez (Cuban Health and Alzheimer Study), Karen Ritchie(Etude Santé Psychologique et Traitement), Kenichi Meguro (Kurihara Study), Martin van Boxtel (Maastricht Ageing Study), Marcia Scazufca (São Paulo Ageing & Health Study), Antonio Guaita (Invecchiamento Cerebrale in Abbiategrasso), Liang-Kung Chen (I-Lan Longitudinal Aging Study), Suzana Shahar (LRGS TUA: Neuroprotective Model for Healthy Longevity among Malaysian Older Adults), Jacqueline Dominguez (Marikina Memory and Aging Project), Murali Krishna (Mysore studies of Natal effects on Ageing and Health), Mary Ganguli (Monongahela Valley Independent Elders Survey), Kaarin J. Anstey (Personality and Total Health Through Life Project), Michael Crowe (Puerto Rican Elderly: Health Conditions study), Mary N. Haan (Sacramento Area Latino Study on Aging), Shuzo Kumagai (Sasaguri Genkimon Study), Tze Pin Ng (Singapore Longitudinal Ageing Studies (I)), Henry Brodaty (Sydney Memory and Ageing Study), Kenichi Meguro (Tajiri Project), Richard Mayeux and Nicole Schupf (Washington Heights Inwood and Columbia Aging Project).
COSMIC NIH grant investigators: Perminder Sachdev: Scientia Professor of Neuropsychiatry; Co-Director, Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney; Director, Neuropsychiatric Institute, Prince of Wales Hospital, Sydney, Australia. Mary Ganguli: Professor of Psychiatry, Neurology, and Epidemiology, University of Pittsburgh. Ronald Petersen: Professor of Neurology; Director, Mayo Clinic Alzheimer's Disease Research Center and the Mayo Clinic Study of Aging. Richard Lipton: Edwin S. Lowe Professor and Vice Chair of Neurology, Albert Einstein College of Medicine. Karen Ritchie: Professor and Director of the Neuropsychiatry Research Unit of the French National Institute of Research (INSERM U1061). Ki-Woong Kim: Professor of Brain and Cognitive Sciences, Director of National Institute of Dementia of Korea. Louisa Jorm: Director, Centre for Big Data Research in Health and Professor, Faculty of Medicine, UNSW Sydney, Australia. Henry Brodaty: Scientia Professor of Ageing & Mental Health; Co-Director, Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney; Director, Dementia Collaborative Research Centre (DCRC); Senior Consultant, Old Age Psychiatry, Prince of Wales Hospital.
Funding for COSMIC comes from a National Health and Medical Research Council of Australia Program Grant (ID 1093083), the National Institute On Aging of the National Institutes of Health under Award Number RF1AG057531, and philanthropic contributions to The Dementia Momentum Fund (UNSW Project ID PS38235). Funding for the contributing studies is as follows:
H70: The Swedish Research Council (2015-02830, 2013-8717), Swedish Research Council for Health, Working Life and Welfare (2013-2300, 2013-2496), the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALF-716681), Alzheimerfonden, Hjärnfonden, The Alzheimer's Association Stephanie B. Overstreet Scholars (IIRG-00-2159), The Alzheimer's Association Zenith Award (ZEN-01-3151)
HELIAD: IIRG-09133014 from the Alzheimer's Association; 189 10276/8/9/2011 from the ESPA-EU program Excellence Grant (ARISTEIA), which is co-funded by the European Social Fund and Greek National resources, and ΔΥ2β/οικ.51657/14.4.2009 from the Ministry for Health and Social Solidarity (Greece);
KLOSCAD: the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [Grant No. HI09C1379 (A092077)];
LEILA75+: the Interdisciplinary Centre for Clinical Research at the University of Leipzig (Interdisziplinäres Zentrum für Klinische Forschung/IZKF; grant 01KS9504);
SAS: Shanghai Brain-Intelligence Project [STCSM 16JC1420500], Natural Science Foundation and Major Basic Research Program of Shanghai [16JC1420100], National Natural Science Foundation of China , Scientific Research Plan Project of Shanghai Science and Technology Committee [17411950701, 17411950106], Shanghai Municipal Science and Technology Major Project (No.2018SHZDZX01), ZHANGJIANG LAB, Tianqiao and Chrissy Chen Institute, and the State Key Laboratory of Neurobiology and Frontiers Center for Brain Science of Ministry of Education, Fudan University.
ZARADEMP: Supported by grants from the Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness, Madrid, Spain (grants 94/1562, 97/1321E, 98/0103, 01/0255, 03/0815, 06/0617, G03/128), and the Fondo Europeo de Desarrollo Regional (FEDER) of the European Union and Gobierno de Aragón, Group #19.
The sponsors were not involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funders.
Conflict of Interest
The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures involving human subjects/patients were approved by the University of New South Wales Human Research Ethics Committee (Ref: # HC12446). Each of the six contributing studies had previously obtained ethics approval from their respective institutional review boards and written informed consent was obtained from all subjects/patients.